Price $28.93 |
Market Cap
2.98B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
15.2
|
P/B
1.11
|
P/S
0.99
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
7.5
|
Op. Cash Flow
414.4K
|
FCF
4.5
|
|
Op. Margin
13.90%
|
Net Margin
7.50%
|
ROE
8.50%
|
ROI
6.10%
|
|
ROA
3.50%
|
EPS Growth
30.60%
|
Current Ratio
1.2
|
Debt/Equity
124.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 13.4M | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $16.80 | - | - | 617.5M | Strong Buy |
| Lannett Company, Inc. (LCI) | $4.85 | - | - | 215.8M | Strong Buy |
| Medical Transcription Billing (MTBC) | $4.58 | - | - | 58M | Strong Buy |
| Champions Oncology Inc (CSBR) | $9.84 | - | - | 137.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
